New York Life Trust’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$2K Sell
29
-1,352
-98% -$106K 0.1% 168
2016
Q4
$104K Buy
+1,381
New +$99.7K 0.49% 70
2016
Q3
Sell
-424
Closed -$29K 235
2016
Q2
$29K Sell
424
-145
-25% -$10.7K 0.14% 169
2016
Q1
$41K Buy
569
+477
+518% +$31.2K 0.18% 156
2015
Q4
$6K Sell
92
-733
-89% -$51.3K 0.03% 207
2015
Q3
$53K Buy
+825
New +$60.9K 0.24% 141

Other funds holding EMN

New York Life Trust's EMN Position: Q1 2017 in Review

New York Life Trust reduced its Eastman Chemical (EMN) stake by 98% in Q1 2017, selling an estimated $106K and leaving 29 shares worth $2K. The position accounts for 0.1% of the portfolio, ranked #168.

New York Life Trust first reported a position in EMN in Q3 2015 and has held it in 6 quarters since. The position peaked at $104K in Q4 2016. 605 funds tracked by Wall St. Rank hold EMN as of Q1 2017.

  • New York Life Trust held 29 shares of Eastman Chemical worth $2K as of Q1 2017.
  • New York Life Trust sold 1,352 Eastman Chemical shares in Q1 2017, an estimated $106K.
  • Eastman Chemical made up 0.1% of New York Life Trust's portfolio in Q1 2017, its #168 holding.
  • New York Life Trust first reported a position in Eastman Chemical in Q3 2015 and has held it in 6 quarters since.
  • New York Life Trust's Eastman Chemical position peaked at $104K in Q4 2016.
  • 605 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.